First report of clinical response to Venetoclax in Early T-cell Precursor Acute Lymphoblastic Leukemia
JCO Precis Oncol
.
2018:2:PO.18.00127.
doi: 10.1200/PO.18.00127.
Epub 2018 Aug 22.
Authors
Yazan Numan
1
,
Mansour Alfayez
1
,
Abhishek Maiti
2
,
Yesid Alvarado
1
,
Elias J Jabbour
1
,
Alessandra Ferrajoli
1
,
Sergej N Konoplev
3
,
Hagop M Kantarjian
1
,
Prithviraj Bose
1
Affiliations
1
Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
2
Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
3
Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX.
PMID:
31080940
PMCID:
PMC6508880
DOI:
10.1200/PO.18.00127
No abstract available
Grants and funding
P30 CA016672/CA/NCI NIH HHS/United States